PGP and neoplasm: Experiments showed that diosgenin decreased the MDR of HepG2/adriamycin cells, significantly inhibited the expression of P-gp, and increased the accumulation of adriamycin in HepG2/adriamycin cells, indicating that diosgenin is an effective MDR reversal agent and a potential adjuvant drug for tumor chemotherapy.